Clinical Development of AKT Inhibitors and Associated Predictive Biomarkers to Guide Patient Treatment in Cancer Medicine is a research paper published in Pharmacogenomics and Personalized Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 56 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCATS NIH HHS
Grant: UL1 TR003167
Cancer Research UK
Grant: 21773
NCI NIH HHS
Grant: P30 CA016672
FWCI
2.74
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals